Gil Blum
Stock Analyst at Needham
(2.16)
# 2,769
Out of 4,908 analysts
402
Total ratings
37.96%
Success rate
-3.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Reiterates: Underperform | n/a | $13.62 | - | 36 | Jul 22, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.61 | +283.14% | 29 | Jul 21, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $65.93 | +22.86% | 24 | Jul 8, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $13.94 | +108.03% | 17 | Jun 30, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $2.58 | +597.67% | 6 | May 15, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $3.63 | +147.93% | 4 | May 14, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $68.28 | +53.78% | 23 | Dec 10, 2024 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $7 → $5 | $1.76 | +184.09% | 19 | Jul 10, 2025 | |
| IMAB I-Mab | Reiterates: Buy | $5 | $2.08 | +140.38% | 15 | Jul 9, 2025 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $8 | $6.54 | +22.32% | 24 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.63 | +204.18% | 29 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.24 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $42 | $3.37 | +1,146.29% | 21 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.08 | +380.77% | 17 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $12.15 | +229.22% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.27 | +87.35% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $11.25 | +140.00% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $37.15 | +91.12% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.85 | +386.49% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.80 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.28 | +290.63% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.22 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $4.92 | +875.61% | 9 | Aug 2, 2024 |
Sarepta Therapeutics
Jul 22, 2025
Reiterates: Underperform
Price Target: n/a
Current: $13.62
Upside: -
Autolus Therapeutics
Jul 21, 2025
Reiterates: Buy
Price Target: $10
Current: $2.61
Upside: +283.14%
CRISPR Therapeutics AG
Jul 8, 2025
Reiterates: Buy
Price Target: $81
Current: $65.93
Upside: +22.86%
Celcuity
Jun 30, 2025
Reiterates: Buy
Price Target: $29
Current: $13.94
Upside: +108.03%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $2.58
Upside: +597.67%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $3.63
Upside: +147.93%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $68.28
Upside: +53.78%
Mereo BioPharma Group
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $1.76
Upside: +184.09%
I-Mab
Jul 9, 2025
Reiterates: Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Recursion Pharmaceuticals
Jul 8, 2025
Reiterates: Buy
Price Target: $8
Current: $6.54
Upside: +22.32%
Jul 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.63
Upside: +204.18%
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.24
Upside: -
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $3.37
Upside: +1,146.29%
May 15, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.08
Upside: +380.77%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $12.15
Upside: +229.22%
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $4.27
Upside: +87.35%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $11.25
Upside: +140.00%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $37.15
Upside: +91.12%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.85
Upside: +386.49%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.80
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.28
Upside: +290.63%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.22
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $4.92
Upside: +875.61%